Allergan Aesthetics
Carol Chappie has a diverse work experience spanning over several companies. Carol recently worked at Allergan Aesthetics as an Associate Director, Pipeline Forecasting & Commercial Analytics. Prior to that, they held various roles at Allergan Aesthetics and AbbVie, including Associate Director, Global FP&A, where they established FP&A processes and managed planning processes and reporting packages. Carol also served as an Associate Director, Finance - Global Marketing & Commercial Operations at AbbVie, where they led the Long Range Planning process and developed a Commercial Model for Parkinson's Disease products. Additionally, Carol Chappie has experience at Turtle Wax, WD-40 Company, and Travel University International, where they held roles in finance, planning, and general operations management.
Carol Chappie obtained a Bachelor of Business Administration (BBA) degree in International Business & Management Information Systems from the University of Hawaii at Manoa from 1987 to 1990. Carol then pursued an Executive Leadership (MSEL) degree at the University of San Diego from 1999 to 2001. Additionally, they also hold a Bachelor of Business Administration (BBA) degree in International Business & Management Information Systems from the University of Hawaii at Manoa.
Allergan Aesthetics
7 followers
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first. That’s why we dedicate ourselves, every day, united by a single purpose: empowering confidence. For our customers, their patients and one another. Review our LinkedIn community guidelines at https://news.abbvie.com/social-media/